大型多种族生物样本库中IBD常见与罕见变异的预测及外显率
研究利用BioMe生物样本库29358名多种族个体的外显子测序和SNP阵列数据,计算并整合欧洲、非裔美国人和德系犹太人参考数据集的多基因风险评分(PRS),发现整合不同祖先关联数据可改善各人群IBD预测,并验证了VEO-IBD基因ADAM17和LRBA的高外显率。
要点
- 整合不同祖先的PRS可改善所有BioMe人群的IBD预测。
- 非欧洲人群预测效力较低,部分因非洲IBD病例对照参考样本量较小。
- ADAM17和LRBA显性模型外显率高,LRBA杂合携带与LRBA及CTLA-4表达降低相关。
核心结论
- 整合不同祖先的遗传关联数据可提升跨人群IBD预测效能。
- 非洲人群遗传多样性有助于泛化部分VEO-IBD基因关联。
- 应优先扩大非裔美国人IBD病例收集以减少健康差异并深化病理生理认识。
研究设计与样本
- 基于BioMe生物样本库29358名多种族、随机招募个体的外显子测序和SNP阵列数据。
- PRS来自欧洲、非裔美国人和德系犹太人参考病例对照研究及三者meta-GWAS。
- 采用回归评估不同PRS组合对欧洲、德系犹太人、西班牙裔和非裔美国人IBD状态的预测。
- 通过估计各BioMe人群的遗传外显率评估VEO-IBD相关基因的罕见变异。
主要发现
- 整合不同祖先关联数据的风险评分改善了BioMe所有人群的IBD预测,并显著改善欧洲 ancestry UK Biobank个体的预测。
- 非欧洲人群预测效力较低,部分反映非洲IBD病例对照参考样本量显著较小。
- 在BioMe中重复了ADAM17和LRBA与VEO-IBD的关联,显性模型外显率高。
- 非洲优势的LRBA蛋白改变等位基因杂合携带与LRBA和CTLA-4表达显著降低及T细胞活化相关。
临床怎么用
- PRS预测IBD需考虑祖先多样性,整合多祖先数据可提升预测。
- 对VEO-IBD相关基因如ADAM17和LRBA可关注罕见变异的外显率。
- LRBA杂合携带者可能需监测LRBA/CTLA-4表达及免疫异常。
局限性
- 非洲IBD病例对照参考样本量较小,限制非欧洲人群预测效力。
- 研究基于健康系统生物样本库,随机招募,外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND AIMS: Polygenic risk scores (PRS) may soon be used to predict inflammatory bowel disease (IBD) risk in prevention efforts. We leveraged exome-sequence and single nucleotide polymorphism (SNP) array data from 29,358 individuals in the multiethnic, randomly ascertained health system-based BioMe biobank to define effects of common and rare IBD variants on disease prediction and pathophysiology. METHODS: PRS were calculated from European, African American, and Ashkenazi Jewish (AJ) reference case-control studies, and a meta-GWAS run using all three association datasets. PRS were then combined using regression to assess which combination of scores best predicted IBD status in European, AJ, Hispanic, and African American cohorts in BioMe. Additionally, rare variants were assessed in genes associated with very early-onset IBD (VEO-IBD), by estimating genetic penetrance in each BioMe population. RESULTS: Combining risk scores based on association data from distinct ancestral populations improved IBD prediction for every population in BioMe and significantly improved prediction among European ancestry UK Biobank individuals. Lower predictive power for non-Europeans was observed, reflecting in part substantially lower African IBD case-control reference sizes. We replicated associations for two VEO-IBD genes, ADAM17 and LRBA, with high dominant model penetrance in BioMe. Autosomal recessive LRBA risk alleles are associated with severe, early-onset autoimmunity; we show that heterozygous carriage of an African-predominant LRBA protein-altering allele is associated with significantly decreased LRBA and CTLA-4 expression with T-cell activation. CONCLUSIONS: Greater genetic diversity in African populations improves prediction across populations, and generalizes some VEO-IBD genes. Increasing African American IBD case-collections should be prioritized to reduce health disparities and enhance pathophysiological insight.
引用
- Gettler K, Levantovsky R, Moscati A, et al. Common and Rare Variant Prediction and Penetrance of IBD in a Large, Multi-ethnic, Health System-based Biobank Cohort. Gastroenterology. 2020. PMID: 33359885. doi:10.1053/j.gastro.2020.12.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。